होम › क्रोनिक लिम्फोसाइटिक ल्यूकेमिया › ओहायो › Columbus
Columbus, OH में क्रोनिक लिम्फोसाइटिक ल्यूकेमिया क्लिनिकल ट्रायल
Columbus (लगभग 30 मील के भीतर) की साइटों पर क्रोनिक लिम्फोसाइटिक ल्यूकेमिया के लिए 28 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
भर्ती जारीचरण 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- और 8 अन्य
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
भर्ती जारीअवलोकनात्मक अध्ययनस्वस्थ स्वयंसेवकों का स्वागत है
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- और 8 अन्य
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
भर्ती जारीचरण 3
- Study Site 104, Columbus
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
भर्ती जारीचरण 3
- Ohio State University Comprehensive Cancer Center, Columbus
Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
भर्ती जारीचरण 2
- The Ohio State University, Columbus
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
भर्ती जारीचरण 1/2
- Research Site, Columbus
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
भर्ती जारीचरण 1
- The James Cancer Hospital and Solove Research Institute, Columbus
Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
भर्ती जारीचरण 3
- OSU Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
भर्ती जारीचरण 1/2
- The Ohio State University Wexner Medical Center, Columbus
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
भर्ती जारीचरण 1
- The Ohio State University, Columbus
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
भर्ती जारीचरण 1
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
भर्ती जारीचरण 1
- The Ohio State University, Columbus
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
भर्ती जारीचरण 4
- Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
भर्ती जारीचरण 4
- Ohio State University Comprehensive Cancer Center, Columbus
Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
भर्ती जारीचरण 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
भर्ती जारीचरण 2
- The Ohio State University /ID# 230439, Columbus
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
भर्ती जारीचरण 2
- The Ohio State University Comprehensive Cancer Center, Columbus
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
भर्ती जारीचरण 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
भर्ती जारीचरण 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
HPC Offered for PRESERVE Expansion
भर्ती जारीअवलोकनात्मक अध्ययन
- The Ohio State University Medical Center, Columbus
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
भर्ती जारीचरण 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
अन्य शहरों में क्रोनिक लिम्फोसाइटिक ल्यूकेमिया ट्रायल
- Boston, MA31 अध्ययन
- Durham, NC27 अध्ययन
- Washington, DC22 अध्ययन
- Seattle, WA20 अध्ययन
- Rochester, MN19 अध्ययन
- New York City, NY18 अध्ययन
- Houston, TX17 अध्ययन
- Baldwin Park, CA16 अध्ययन
- Milwaukee, WI15 अध्ययन
- Cincinnati, OH14 अध्ययन
- Chicago, IL14 अध्ययन
- Nashville, TN13 अध्ययन
Columbus में अन्य अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर56 अध्ययन
- स्तन कैंसर39 अध्ययन
- अंडाशय का कैंसर39 अध्ययन
- कैंसर (सभी प्रकार)38 अध्ययन
- फेफड़ों का कैंसर37 अध्ययन
- तीव्र माइलोइड ल्यूकेमिया35 अध्ययन
- मेटास्टेटिक कैंसर27 अध्ययन
- एंडोमेट्रियल कैंसर25 अध्ययन
- कोलोरैक्टल कैंसर24 अध्ययन
- प्रोस्टेट कैंसर24 अध्ययन
- मल्टीपल मायलोमा24 अध्ययन
- मेलेनोमा21 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।